Loading...
Loading...
Among the 9 tracked institutional investors we monitor, DAWNGBX (DAY ONE BIOPHARMACEUTICALS I) is held with a combined value of $383.42M across 21,434,658 shares. The largest holder is BlackRock, Inc. with a position worth $151.03M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 6 funds reduced their position.
Total Institutional Value
$383.42M
Total Shares Held
21,434,658
Institutional Holders
9
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $151.03M | 0.00% | -20.3% |
| 2 | STATE STREET CORP | $61.53M | 0.00% | -33.1% |
| 3 | VANGUARD GROUP INC | $58.55M | 0.00% | New |
| 4 | MILLENNIUM MANAGEMENT LLC | $41.33M | 0.02% | +42.8% |
| 5 | SOROS FUND MANAGEMENT LLC | $33.00M | 0.36% | New |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $27.81M | 0.04% | -0.6% |
| 7 | CITADEL ADVISORS LLC | $8.98M | 0.00% | -75.4% |
| 8 | Point72 Asset Management, L.P. | $684.75K | 0.00% | -79.6% |
| 9 | FMR LLC | $506.83K | 0.00% | -99.6% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of DAWNGBX with a position worth $151.03M, representing 0.00% of their portfolio. In total, 9 institutional investors hold DAWNGBX with a combined value of $383.42M.
In the most recent quarter, 2 funds opened a new position in DAWNGBX. Additionally, 1 increased their holdings and 6 reduced their positions.
Institutional investors hold $383.42M worth of DAWNGBX stock across 9 positions. The largest institutional holder is BlackRock, Inc. with $151.03M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For DAWNGBX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their DAWNGBX positions.